Parliament Workbench
Data: Motions & questions to 19 Nov 2026 · Votes to 12 Nov 2026

Members' Business Motion · S7M-01394 · Session 7

Octopus Clinical Trial for Primary and Secondary Progressive Multiple Sclerosis

Lodged by George Adam SNP Lodged 29 Sep 2026 20 supporters Cross-party support

The motion

That the Parliament welcomes the recent interim results from the Octopus clinical trial for primary and secondary progressive Multiple Sclerosis (MS), which has indicated that alpha-lipoic acid has early promise as a potential treatment; notes that Octopus is designed to test potential treatments up to three times faster than traditional trials by using the multi-arm, multi-stage (MAMS) approach; understands that the trial is testing repurposed treatments and, at this stage, has tested metformin and alpha-lipoic acid; welcomes that alpha-lipoic acid will now continue to the next stage of the trial, which will see hundreds more people recruited; believes that Octopus demonstrates that an innovative approach to clinical trials is possible with MS and that this encouraging news is a step in the right direction to finding treatments to slow or stop progression of MS; anticipates that new treatments to be tested will be announced in early 2027 and that the final results of the alpha-lipoic stage of the trial will be available in 2029; considers this to be a positive development for people living with progressive MS, including in Paisley, who currently have limited treatment options, and wishes staff and participants well as the trial continues.

Signatures by party

20 MSPs besides the lodger · 7 from other parties
SNP 13Con 3Lab 2Reform 2

Party on the day each MSP signed. Signing a motion is voluntary and not whipped. Who signs whose motions

Vote

No recorded vote on this motion. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.

Supporters

20 MSPs

SNP 13 Con 3 Lab 2 Reform 2

Show all 20 supporters by party

SNP 13

Con 3

Lab 2

Reform 2

Party shown is each supporter’s party when the motion was published.

In the Official Report

No contribution in the Official Report cites S7M-01394 by reference.